Biological medication for rheuma

RX_RHEUMA_BIOLOGICAL

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AA24|L04AC03|L04AB04|L04AB01|L04AB06|L04AB02|L04AB05|L04AA26|L01XC02|L04AC10|L04AC07|L04AC05

3695

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

3552

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

3552

diagram downward connector

Include endpoints None

3552

diagram downward connector
RX_RHEUMA_BIOLOGICAL

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 3552 2196 1356
Unadjusted prevalence (%) 1.00 1.11 0.86
Mean age at first event (years) 46.81 46.45 47.40

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.34 [1.32, 4.14] 3.5e-3 63
15 years 0.01 1.60 [0.88, 2.90] 1.2e-1 43
5 years 0.00 1.63 [0.84, 3.17] 1.5e-1 13
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_RHEUMA_BIOLOGICAL – Biological medication for rheuma
GWS hits: 2

Survival analyses between endpoints

↥

Plot

before Biological medication for rheuma
after Biological medication for rheuma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Biological medication for rheuma

↥